Modified CEUS LI-RADS using Sonazoid for the diagnosis of hepatocellular carcinoma
Katsutoshi Sugimoto1, Naohisa Kamiyama2, Tatsuya Kakegawa1
1Department of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.
Ultrasonography (Seoul, Korea)
|June 21, 2023
Abstract:
This review outlines several modified versions of the contrast-enhanced ultrasonography Liver Imaging Reporting and Data System (CEUS LI-RADS) that utilize Sonazoid. Furthermore, it discusses the advantages and challenges of diagnosing hepatocellular carcinoma using these guidelines, as well as the authors' expectations and opinions regarding the next CEUS LI-RADS version. It is possible that Sonazoid could be incorporated into the next version of CEUS LI-RADS.
Keywords:
Contrast-enhanced ultrasoundHepatocellular carcinomaKupffer cell agentsModified CEUS LI-RADSSonazoid

